Ian Jacobs | |
---|---|
Vice Chancellor and President of UNSW | |
In office February 2015 –January 2022 | |
Personal details | |
Born | 6 October 1957 |
Alma mater | Trinity College, Cambridge (BA, MA) University College London (MBBS) University of London (MD) |
Occupation | academic medical doctor gynaecological oncologist researcher |
Ian Jacobs (born 6 October 1957 [1] ) is an academic, medical doctor, gynaecological oncologist, charity founder [2] and university leader from the UK, with dual British and Australian citizenship. [3]
He began as the ninth president and vice-chancellor of the University of New South Wales in Australia in February 2015. Jacobs announced his resignation in January 2021, to take effect at the beginning of 2022. [4]
Jacobs was born in the East End of London and raised in Cockfosters in North London. [5]
Jacobs is an alumnus of Trinity College, Cambridge, and the Middlesex Hospital Medical School, which is now part of University College London. He received a bachelor of arts and master of arts in medicine and law from Cambridge in 1980 and 1983, respectively. He qualified as a doctor of medicine (MBBS) from Middlesex Hospital Medical School in 1983. Jacobs was awarded a medical doctorate from the University of London in 1991. [6]
Jacobs was the first in his family to gain a tertiary education, benefitting from the era of publicly funded education in the UK. [7]
After qualifying as a doctor, Jacobs worked as a junior doctor at the Middlesex Hospital and at Mount Vernon Hospital. In 1984, he commenced specialist training in obstetrics and gynaecology at the Royal London Hospital and then Addenbrooke's Hospital, Cambridge, which he completed in 1990. [6]
Also in 1984, Jacobs founded The Eve Appeal (first called the Gynaecology Cancer Research Fund), a charity with the aim of raising funds for research in gynaecologic cancer. In 1985, he began a program of research into ovarian cancer screening. [2] He was subsequently Medical Director of the charity as well as Emeritus Trustee. [6] [8]
From 1990 to 1991, Jacobs received a fellowship from the Medical Research Council to research cancer genetics at Duke University. [6] He became a member of the Royal College of Obstetricians and Gynaecologists in 1991 [9] and received a Cancer Research Campaign (now Cancer Research UK) McElwain fellowship at Cambridge University from 1992 to 1994. [6] He completed his subspecialist training in gynaecologic oncology at St Bartholomew's Hospital and the Royal Marsden Hospital in 1996, and began working as a consultant and senior lecturer at Barts and the London School of Medicine and Dentistry in the same year. [6] Jacobs was promoted to Professor of Gynaecological Cancer at the Queen Mary University of London in 1999 [10] and was Director of the Cancer Institute and Associate Research Dean before joining University College London (UCL) in 2004 as the head of the gynaecologic oncology research department. [6] [11] [12] At UCL, Jacobs established the Elizabeth Garrett Anderson Institute for Women's Health (iFWH), [12] [13] the Ugandan Women's Health Initiative (UWHI), [14] [15] [16] and the UCLH/UCL Biomedical Research Centre. [17] [18] [19] From 2009 to 2011, Jacobs was dean of the Faculty of Biomedical Sciences. [20]
After seven years, he departed from UCL in 2011 to take up the position of vice-president of the University of Manchester and the dean of its Faculty of Medical and Human Sciences. [10] He also led the Manchester Academic Health Science Centre, which partnered the university with six NHS hospitals. [21] [22] While in Manchester, Jacobs founded the Northern Health Science Alliance (NHSA), involving leading universities, Academic Health Science Networks and NHS trusts across the north of England. [23]
In 2015, Jacobs relocated from the UK to Sydney, Australia, after he was appointed president and vice-chancellor of the University of New South Wales (UNSW Sydney). [24] [25]
In his first year at UNSW Sydney, Jacobs launched the UNSW 2025 Strategy, a 10-year strategic plan to enhance the university's global impact and reputation. The strategy, published in October 2015 after wide-ranging consultation with the UNSW Sydney community, incorporated Jacobs’ belief in universities as the drivers of societal and economic transformation. [26]
Jacobs initiated and was chief investigator for the following ovarian cancer research programs, which were funded by a combination of the Medical Research Council (MRC), the National Institute for Health Research (NIHR), Cancer Research UK (CRUK) and The Eve Appeal:
Since the early 2000s, Jacobs’ research programs have received approximately AUD $100 million in funding and resulted in more than 400 publications with an h-index greater than 85. [27] [34]
In May 2021, the results of the UKCTOCS were published in The Lancet. The research found that although ovarian cancer can be detected early and before women develop symptoms, this does not translate into saving lives. [29] Jacobs wrote an account of his 35-year involvement in the research in The Conversation, expressing his sadness and disappointment that the study did not find the outcome for which the research team had hoped. [35]
Jacobs is founder, non-executive director and consultant to Abcodia, a University College London spin-out company involved in biomarker discovery and development. [2] [36] [37]
Jacobs is married to Chris Jacobs, a nurse and genetic counsellor whom he met at Middlesex Hospital. They have three children. His great grandparents were migrants from Poland and Russia. His parents grew up in East London and until retiring ran a retail pharmacy. [38] "Jacobs' Journey" (PDF). UniLife. University Hospital of South Manchester NHS Foundation Trust . Retrieved 7 May 2015.
University College Hospital (UCH) is a teaching hospital in the Fitzrovia area of the London Borough of Camden, England. The hospital, which was founded as the North London Hospital in 1834, is closely associated with University College London (UCL), whose main campus is situated next door. The hospital is part of the University College London Hospitals NHS Foundation Trust.
Sir Michael James Paul Arthur FMedSci is a British academic who was the tenth provost and president of University College London between 2013 and January 2021. Arthur had previously been chairman of the Russell Group of UK universities and the vice-chancellor of the University of Leeds between September 2004 and 2013.
The School of Medical Sciences at the University of Manchester is one of the largest in the United Kingdom with around 6,000 undergraduates, 3,000 postgraduates and 2,000 staff. It is the third oldest medical school in England and the largest medical school in the United Kingdom. The Faculty is a member of the Manchester Academic Health Science Centre and has four affiliated teaching hospitals at Manchester Royal Infirmary, Wythenshawe Hospital, Salford Royal Hospital and the Royal Preston Hospital.
Stuart Campbell DSc FRCPEd FRCOG FACOG, was born in Glasgow, Scotland, and graduated from the medical school of Glasgow University. During his training he worked with Ian Donald, who had published some of the first papers on the use of ultrasound in obstetrics.
Yvonne Helen Carter was a British general practitioner and Dean of the Warwick Medical School, a post she took up in 2004, after being the Vice-Dean. Warwick Medical School is Britain's first medical school to only accept applications from graduates.
The Royal Free London NHS Foundation Trust is an NHS foundation trust based in London, United Kingdom. It comprises Royal Free Hospital, Barnet Hospital, Chase Farm Hospital, as well as clinics run by the trust at Edgware Community Hospital, Finchley Memorial Hospital, and North Middlesex University Hospital. On 1 July 2014, the Barnet and Chase Farm Hospitals NHS Trust was acquired by Royal Free London NHS Foundation Trust, making it one of the largest trusts in the country.
The Eastman Dental Hospital was based on Gray's Inn Road until it co-located with the University College London ear, nose, throat, balance and hearing services on Huntley Street, London, as the Royal National ENT and Eastman Dental Hospitals in October 2019. The hospital continues to provide specialist dental treatment as well as ear, nose, throat, hearing, speech and balance services and is part of the University College London Hospitals NHS Foundation Trust.
Michael J. G. Farthing is British emeritus professor at the University of Sussex, where he was previously its vice-chancellor (2007–2016). His early academic career was in medicine, specialising in gastroenterology.
UCLPartners is an academic health science centre located in London, England. It is the largest academic health science centre in the world, treats more than 1.5 million patients each year, has a combined annual turnover of around £2 billion and includes around 3,500 scientists, senior researchers and consultants.
University College London Hospitals NHS Foundation Trust (UCLH) is an NHS foundation trust based in London, United Kingdom. It comprises University College Hospital, University College Hospital at Westmoreland Street, the UCH Macmillan Cancer Centre, the Royal National ENT and Eastman Dental Hospitals, the Hospital for Tropical Diseases, the National Hospital for Neurology and Neurosurgery, the Royal London Hospital for Integrated Medicine and the Royal National Throat, Nose and Ear Hospital.
Sir Edward Byrne is a neuroscientist who served as Principal of King's College London from August 2014 until January 2021. He was previously Vice-Chancellor of Monash University.
The UCLH Biomedical Research Centre is a biomedical research centre based in London. It is a partnership between University College London Hospitals NHS Foundation Trust (UCLH), University College London (UCL) the National Institute for Health and Care Research (NIHR) and UCLPartners. It was one of the original five Comprehensive Biomedical Research Centres established by the NIHR in April 2007.
Abcodia is a company that focuses on biomarkers for cancer screening. Its aim is to discover biomarkers that can be used for the early detection of cancer.
Isaac Folorunso AdewoleFAS is a Nigerian professor of gynaecology and obstetrics. He was minister of health of Nigeria from November 2015 to May 2019 under the Cabinet of President Muhammadu Buhari. He is a former vice-chancellor of the University of Ibadan, and president of the African Organisation for Research and Training in Cancer.
Professor Sir Ian Andrew Greer is a medical doctor who is the President and Vice Chancellor of Queen's University Belfast and formerly Vice-President of the University of Manchester and Dean of the Faculty of Medical and Human Sciences. He was Regius Professor of Obstetrics and Gynaecology at the University of Glasgow 2001−2007, Dean at Hull York Medical School 2007–2010, then Pro-Vice-Chancellor of the Faculty of Health and Life Sciences at the University of Liverpool 2010−2015.
(Robert) Charles Swanton is British physician scientist specialising in oncology and cancer research. Swanton is a senior group leader at London's Francis Crick Institute, Royal Society Napier Professor in Cancer and thoracic medical oncologist at University College London and University College London Hospitals, co-director of the Cancer Research UK (CRUK) Lung Cancer Centre of Excellence, and Chief Clinician of Cancer Research UK.
Usha Menon is Professor of Gynaecological Cancer at University College London, described as "one of Britain’s foremost specialists in gynaecological cancer".
Sir Stephen Huw Powis is national medical director for England, in the National Health Service (NHS), appointed at the start of 2018 to succeed Sir Bruce Keogh. He is also a professor of renal medicine at University College London.
Jonas Henrik Kellgren was a British physician and the first professor of rheumatology in the United Kingdom at the University of Manchester. He became Vice-Chancellor of the university and dean of the institution's medical school. He was an expert adviser to the World Health Organization and earned a Canada Gairdner International Award for his work.